FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Annelie Siegemund

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Anatomy

Blood Platelets

Procedures

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
Steffen Desch; Ingo Eitel; Georg Fürnau; Philipp Lurz; Ute Scholz; Gerhard Schuler; Annelie Siegemund; Natalie Adam; Suzanne de Waha; Sabrina Wetzel; Holger Thiele
Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction.
Falko H Herrmann; Karin Wulff; Rüdiger Strey; Annelie Siegemund; Jan Astermark; Sam Schulman
Variability of clinical manifestation of factor VII-deficiency in homozygous and heterozygous subjects of the European F7 gene mutation A294V.
Matus Rehak; Jiri Rehak; Marc Müller; Susanne Faude; Frank Faude; Annelie Siegemund; Vera Krcova; Ludek Slavik; Dirk Hasenclever; Markus Scholz; Peter Wiedemann
The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Annelie Siegemund (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Steffen Desch; Ingo Eitel; Georg Fürnau; Philipp Lurz; Ute Scholz; Gerhard Schuler; Annelie Siegemund; Natalie Adam; Suzanne de Waha; Sabrina Wetzel; Holger Thiele
Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction.
Clinical research in cardiology : official journal of the German Cardiac Society 2012;101(2):117-24.
2008: Falko H Herrmann; Karin Wulff; Rüdiger Strey; Annelie Siegemund; Jan Astermark; Sam Schulman
Variability of clinical manifestation of factor VII-deficiency in homozygous and heterozygous subjects of the European F7 gene mutation A294V.
Haematologica 2008;93(8):1273-5.
2008: Matus Rehak; Jiri Rehak; Marc Müller; Susanne Faude; Frank Faude; Annelie Siegemund; Vera Krcova; Ludek Slavik; Dirk Hasenclever; Markus Scholz; Peter Wiedemann
The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
Thrombosis and haemostasis 2008;99(5):925-9.
2007: Yesim Dargaud; Roger Luddington; Elaine Gray; Claude Negrier; Thomas Lecompte; Sirak Petros; John Hogwood; Jean Claude Bordet; Veronique Regnault; Annelie Siegemund; Trevor P Baglin
Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study.
British journal of haematology 2007;139(2):303-9.
2007: Sirak Petros; Thomas Siegemund; Jens-Uwe Stolzenburg; Annelie Siegemund; Lothar Engelmann
Coagulation monitoring with thrombin generation test during endoscopic extraperitoneal radical prostatectomy for prostate cancer in a patient with severe haemophilia B.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(5):677-9.
2006: J Stöbe; Annelie Siegemund; Harald Achenbach; C Preiss; Rainer Preiss
Evaluation of the pharmacokinetics of dalteparin in patients with renal insufficiency.
International journal of clinical pharmacology and therapeutics 2006;44(10):455-65.
2006: Steffen Bassus; Wolfgang Wegert; M Krause; C Escuriola-Ettinghausen; Annelie Siegemund; Sirak Petros; Thomas Scholz; I Scharrer; W Kreuz; Lothar Engelmann; Carl M Kirchmaier
Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.
Platelets 2006;17(6):378-84.
2006: Henri Wallaschofski; Tobias Lohmann; Eva Hild; Anna Kobsar; Annelie Siegemund; Elisabeth Spilcke-Liss; Bettina Hentschel; Christian Stumpf; Werner G Daniel; Christoph D. Garlichs; Martin Eigenthaler
Enhanced platelet activation by prolactin in patients with ischemic stroke.
Thrombosis and haemostasis 2006;96(1):38-44.
2006: Sirak Petros; Thomas Siegemund; Annelie Siegemund; Lothar Engelmann
The effect of different anticoagulants on thrombin generation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006;17(2):131-7.
2006: Jörg Berrouschot; B Schwetlick; G von Twickel; C Fischer; H Uhlemann; Thomas Siegemund; Annelie Siegemund; A Roessler
Aspirin resistance in secondary stroke prevention.
Acta neurologica Scandinavica 2006;113(1):31-5.
2005: Thorsten Klemm; A K Mehnert; Annelie Siegemund; Tobias D Wiesner; Götz Gelbrich; Matthias Blüher; Ralf Paschke
Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2005;113(10):568-72.
2005: Rüdiger F Strey; Annelie Siegemund; Thomas Siegemund; Christine Schubert; Gudrun Schuster; Karin Wulff; Falko H Herrmann
Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders.
Pathophysiology of haemostasis and thrombosis 2005;34(6):279-83.
2004: Henri Wallaschofski; Anna Kobsar; Olga Sokolova; Annelie Siegemund; Holger Stepan; R Faber; Martin Eigenthaler; Tobias Lohmann
Differences in platelet activation by prolactin and leptin.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004;36(7):453-7.
2004: Annelie Siegemund; Sirak Petros; Thomas Siegemund; Ute Scholz; Hans-Juergen Seyfarth; Lothar Engelmann
The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(3):241-4.
2003: Johannes M Albes; Ingeborg M Stöhr; Mirko Kaluza; Annelie Siegemund; Dirk Schmidt; Rüdiger Vollandt; Thorsten Wahlers
Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating.
The Journal of thoracic and cardiovascular surgery 2003;126(5):1504-12.
2003: Thomas Siegemund; Sirak Petros; Annelie Siegemund; Ute Scholz; Lothar Engelmann
Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma.
Thrombosis and haemostasis 2003;90(5):781-6.
2003: Martin Grünewald; Annelie Siegemund; Anja Grünewald; Anke Schmid; Mario Koksch; Christine Schöpflin; Stefanie Schauer; Martin Griesshammer
Plasmatic coagulation and fibrinolytic system alterations in PNH: relation to clone size.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(7):685-95.
2003: Annelie Siegemund; Thomas Siegemund
Plasma factor II levels in carriers of the 20210A prothrombin variant.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):513.
2003: Henri Wallaschofski; Anna Kobsar; Mario Koksch; Annelie Siegemund; Bettina Hentschel; Ulrich Tuschy; Tobias Lohmann; Olga Sokolova; Martin Eigenthaler
Prolactin receptor signaling during platelet activation.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(4):228-35.
2003: Peter Meisel; Annelie Siegemund; R Grimm; Falko H Herrmann; Ulrich John; Christian Schwahn; Thomas Kocher
The interleukin-1 polymorphism, smoking, and the risk of periodontal disease in the population-based SHIP study.
Journal of dental research 2003;82(3):189-93.
2002: Martin Grünewald; Annelie Siegemund; Anja Grünewald; A Konegen; Mario Koksch; Martin Griesshammer
Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect.
Platelets 2002;13(8):451-8.
2002: Martin Grünewald; Annelie Siegemund; Anja Grünewald; A Konegan; Mario Koksch; Martin Griesshammer
Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(6):768-75.
2002: Rüdiger Gerlach; Fabian Tölle; Andreas Raabe; Michael Zimmermann; Annelie Siegemund; Volker Seifert
Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study.
Stroke; a journal of cerebral circulation 2002;33(6):1618-23.
2002: Peter Meisel; Annelie Siegemund; Sylke Dombrowa; Hazem Sawaf; Jutta Fanghaenel; Thomas Kocher
Smoking and polymorphisms of the interleukin-1 gene cluster (IL-1alpha, IL-1beta, and IL-1RN) in patients with periodontal disease.
Journal of periodontology 2002;73(1):27-32.
2001: Hans-Juergen Seyfarth; Annelie Siegemund; Michael Woinke; L Helling; Dietrich Pfeiffer; C Rühlmann
[Recurrent coumarin necrosis in type II protein S deficiency].
VASA. Zeitschrift für Gefässkrankheiten 2001;30(1):72-5.
2001: Mario Koksch; F Zeiger; K Wittig; Annelie Siegemund; C B Reininger; Dietrich Pfeiffer; C Rühlmann
Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2001;21(2):147-54.
2000: Rüdiger Gerlach; Andreas Raabe; Michael Zimmermann; Annelie Siegemund; Volker Seifert
Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures.
Surgical neurology 2000;54(3):260-4; discussion 264-5.